AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05542693 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RNA MCTI CIMATEC HDT 10µg
Description: Adults previously immunized will be randomized to receive a single booster vaccine: experimental (MCTI-CIMATEC-HDT RNA)
Study NCT05542693 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Covishield® - AstraZeneca
Description: Adults previously immunized will be randomized to receive a single booster vaccine comparator (Comirnaty - Pfizer)
Study NCT05542693 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Comirnaty® - Pfizer
Description: Adults previously immunized will be randomized to receive a single booster vaccine comparator (Comirnaty - Pfizer and (Covishield - Oxford/Astrazen).
Study NCT05751694 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Visceral manual treatment
Description: The patient will be placed in a reclining sitting position and triple flexion of the lower limbs to keep the abdominal region relaxed. The therapist will be placed to the right of the patient at the height of the abdomen, with the hands placed in the epigastric area. He will make a skin fold that reduces tension in the area, so that the contact is focused on the visceral tissue of the area. The patient will be asked to take deep breaths, and during the exhalation, the therapist will perform a zigzag movement with vibration of the hands while pulling the tissue caudally. This procedure will be performed for 5 minutes.
Study NCT05751694 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Respiratory listening
Description: The patient and the therapist will be placed in the same position as in the experimental group. The therapist will place his hands in contact with the lower rib cage, and the patient will be asked to take a deep breath. The therapist will not exert any pressure, nor place restrictions on the tissues or movements of the ribcage.
Study NCT05410899 — intervention group
Intervention type: OTHER
Intervention: exercise
Description: Women with urinary incontinence will done exercise including pelvic floor muscle and will taught pelvic floor muscle anatomy, physiology, disorders, treatment of disease
Study NCT06282536 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iruplinalkib
Description: 60 mg on days 1-7, if tolerable, 180 mg from day 8 onwards.
Study NCT06282536 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: surgery
Description: Patients with resectable tumors after neoadjuvant therapy will be treated with surgery.
Study NCT05166395 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Description: 2940 nm Er:YAG laser treatment spread over 3 sessions within 4 weeks on participant's scar on either the head/neck, trunk or extremities.
Study NCT06110104 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: routine physiotherapy program for knee osteoarthritis
Description: The Routine physiotherapy program comprises a combination of closed kinetic chain and open kinetic chain exercises, including straight leg raising, isometric quadriceps, isometric hip adduction, terminal knee extension, semi-squat, and leg press for 6 weeks.
Study NCT06110104 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Retro-walking program
Description: Retro-walking program is about 10 min of supervised retro walking training 3 days a week for 6 weeks at their comfortable walking speed . The participants will be instructed to gradually increase their walking time up to 30 min over the 6-week period.
Study NCT06110104 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: whole body vibration training
Description: whole body vibration is 3 days per week for 6 weeks. During the training, the participants will perform static squat training barefoot on the platform with bent knees (30° and 60°). The distance between the feet was consistent with the shoulders. the duration time, sets and total time will be increased progressively over the 6-week.
Study NCT05111951 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile health-delivered physical exercise and support for physical activity
Description: Mobile health-delivered physical exercise sessions, prescription of an individual exercise-regime and support for physical activity through behavior change techniques.
Study NCT05111951 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mobile health-delivered behavior change techniques.
Description: Mobile health-delivered behavior change techniques following the core elements of the Swedish model for physical activity on prescription.
Study NCT06027489 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music
Description: In the second and third months, participants listened to a song that lasted 29 minutes and 32 seconds for four days (three days before menstruation and the first day of menstruation). The song to be played was determined by examining the literature, the song was composed by researcher Juan Sebastian Martin-Saavedra and was named Occasio Adolore (Music Piece No. 5-559-355 and Phonogram No. 12-105-295) by the author copyright institution of Colombia. registered under. While the researcher is composing the song, it is to create a piece of music that will reduce the pain felt, activate positive emotions and relax the person. The composed song is available online within the scope of the published article (https://soundcloud.com/jss-martin/occasio-adolore).
Study NCT06027489 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Drawing Group
Description: : In the second and third months, the participants will be asked to paint for 29 minutes and 32 seconds (the duration of the intervention was determined in parallel with the music group in order not to create variability between the groups) for four days (three days before menstruation and the first day of menstruation). The type of paint to be used in the drawn picture (dry pen, crayon or watercolor) is left to the availability of the participants, and it will be stated that they prefer colors and drawings that will raise their emotions, focus their drawings and feed positive emotions in the picture to be drawn.
Study NCT05237752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LG00034053
Description: a pan-caspase inhibitor, as a therapeutic agent of osteoarthritis
Study NCT05237752 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: LG00034053
Description: a pan-caspase inhibitor, as a therapeutic agent of osteoarthritis
Study NCT05910411 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inelastic compression
Description: Inelastic compression used in the treatment of lymphedema
Study NCT06005857 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard hand therapy + home digital application-based exercises
Description: Standard post-operative hand rehabilitation and home digital application-based exercises
Study NCT05430672 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: The Thoracic Aortic Stent Graft System (Zylox-Tonbridge Medical Technology Co., Ltd. )
Description: This is a objective performance criteria-controlled study, all subjects meet the criteria will receive the same treatment using the thoracic aortic stent graft system (Zylox-Tonbridge Medical Technology Co., Ltd. ).
Study NCT06005857 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standard hand therapy + home paper-based exercises
Description: Standard post-operative hand rehabilitation and home paper-based exercises
Study NCT06083766 — intervention group
Intervention type: BEHAVIORAL
Intervention: hormone therapy
Description: Determine how gender affirming hormone therapy affects muscle physiology
Study NCT05937685 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BP REACH Intervention
Description: Educational materials, written and digital. Home blood pressure monitor and self management education from BP REACH coach. Monthly coaching calls from BP REACH coach. Medication management by pharmacist
Study NCT06167213 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SAPIEN X4 THV
Description: Implantation of the SAPIEN X4 valve
Study NCT04420052 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment
Description: Osteopaths will executed several high velocity low amplitude (HVLA) techniques on the upper thoracic spine and cervical spine. These techniques are assumed to modulate the sympathetic cervical ganglia and reduce inflammation in chronic rhinosinusitis.~This procedure takes around 15 minutes.
Study NCT04420052 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo manipulation
Description: The osteopath will lay hands without movement on the nose, the throat and the thorax of patients.~This procedure takes around 15 minutes.
Study NCT04614246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BAY1817080
Description: Tablet, oral administration
Study NCT04614246 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Elagolix
Description: Tablet, oral administration
Study NCT04614246 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tablet, oral administration
Study NCT05106270 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Atrial pressure measurement using transseptal puncture sheath
Description: both left and right atrial pressure was measured using transseptal puncture sheath before and after combined procedure
Study NCT05949359 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nintendo RingFit-augmented exercise program
Description: Participants in the NRE group received an 8-week exercise training program using the Nintendo RingFit (60 minutes for each session, two sessions a week). In each session, the participants first performed 5 minutes of walk-up exercises (i.e., simple jogging), followed by 50 minutes of Nintendo RingFit exercises and 5 minutes of cool down exercises.~The exercise intensity, in terms of repetitions, holding time of the exercise and advancement to difficult tasks, progressed gradually in 8 weeks.
Study NCT06331494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Butylphthalide
Description: Butylphthalide Sodium Chloride injection for 10±3 days, oral Butylphthalide soft capsules for day 11±3 to day 180.
Study NCT06331494 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Butylphthalide Placebo injection for 10±3 days, oral Butylphthalide Placebo soft capsules for day 11±3 to day 180.
Study NCT05185817 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pasocovac vaccine
Description: All enrolled post-Allo-SCT participants who meet the inclusion criteria are recruited to study from 3 to 12 months after Allo-HSCT and vaccinated with 2 doses of Pastucovac, with a 4-week (±7 days) interval and a booster dose at an 8-week (±7 days) interval from the second dose.
Study NCT04994639 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BP management with HPI guidance
Description: The hemodynamic condition of the HPI group will be managed by HPI guidance which is derived by arterial pressure waveform information, including Eadyn, SVV, dP/dt.
Study NCT04904029 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital Assessment Routing Tool [DART]
Description: DART is a first contact web-based and mobile health system that uses clinical algorithms to triage patients and recommend management pathways. Participants complete an online web-based questionnaire that follows a clinical reasoning process commonly observed in face-to-face physiotherapy consultations. Based on the participant's answers, the clinical algorithm generates sets of questions, leading up to a triage disposition with recommended management pathway. The triage outcomes with management pathways are classified;~1. Medical care~   * A\&E referral~  * Urgent GP~  * Routine GP~  * Consultant review~2. Physiotherapy care~   * Post-fracture or surgery physiotherapy~  * Physiotherapy referral~  * Physiotherapy referral plus psychosocial support~3. Self-management~   * Self-management with SOS~  * Continue self-management advice
Study NCT04904029 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy-led remote triage (usual care)
Description: Participants will receive usual physiotherapy-led remote triage services by a registered health care professional. This service is either a telephone or video consult and includes any diagnostic procedure (e.g. patient history, remote assessments) and treatment, such as management advise or home-based exercise therapy. Participants may seek help elsewhere or opt-out the study at any point, which will not affect their usual physiotherapy-led remote care
Study NCT06451601 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intermittent hypoxia-hyperoxia therapy
Description: Data on demographics and clinical conditions was gathered. The investigators collect the next features: sex, age, occupation, environment, body mass index, nutritional status, abdominal circumference, hip circumference, smoking, alcohol. Also, the patients performed a 6-minute walking test.~Other Names:~* Hydrokinetotherapy~* Hydrothermotherapy~* Electrotherapy~* Massage therapy~* Kinetotherapy
Study NCT06451601 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia-hyperoxia therapy
Description: Data on demographics and clinical conditions was gathered. The investigators collect the next features: sex, age, occupation, environment, body mass index, nutritional status, abdominal circumference, hip circumference, smoking, alcohol. Also, the patients performed a 6-minute walking test.~Other Names:~* Hydrokinetotherapy~* Hydrothermotherapy~* Electrotherapy~* Massage therapy~* Kinetotherapy
Study NCT05557994 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Method
Description: treatment of mature teeth with apical periodontitis
Study NCT05557994 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Method
Description: treatment of mature teeth with apical periodontitis
Study NCT04706780 — intervention group
Intervention type: OTHER
Intervention: ESP block
Description: ESP block performed using ultrasound guidance. Diaphragmatic excursion was measured using M-mode ultrasound during normal breathing, deep breathing and with the sniff manoeuvre.
Study NCT05407116 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NCI PRO-CTCAE Questionnaire / EORTC QLQ-C30 Questionnaire
Description: PROs data will be collected prospectively via electronic questionnaires (PRO-CTCAE™), which is a patient-reported outcomes measurement system created to assess symptomatic toxicity in patients of cancer clinical research. PRO-CTCAE items evaluate frequency, severity, interference, amount, presence/absence symptoms. Each symptomatic adverse effect is measured by 1-3 features. GI items included nausea, vomiting, flatulence, bloating of the abdomen, constipation, diarrhea, abdominal pain, and loss of control of bowel movements. Urinary symptoms include the urge to urinate suddenly, frequency, urine colour change, loss of urine control (leakage).~Patients will also self-report health-related quality of life (QoL) in real-time, electronic PRO questionnaires (EORTC QLQ CX24, EN 24, C30) about QoL. Question 29 and 30 ask the patients to rate their overall health and QOL respectively during the past week on a scale between 1-7, where one is equivalent to very poor and seven is excellent.
Study NCT05078931 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab 200 mg will be administered as a 30-minute IV infusion every 3 weeks for up to 35 cycles
Study NCT05078931 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Lenvatinib 20mg will be administered orally daily.
Study NCT05247450 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation therapy (FES-t)
Description: Functional electrical stimulation therapy (FES-t) that will use a multichannel device (MyndSearch device).
Study NCT05247450 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physiotherapy
Description: Conventional physiotherapy is the current standard of care for rehabilitation of C5 palsy
Study NCT05247450 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy
Description: Conventional physiotherapy is the current standard of care for rehabilitation of C5 palsy
Study NCT06554106 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular Electrical Stimulation Group
Description: All patients will be taught neck normal joint movement exercises, upper trapezius stretching exercise and posture exercises. In addition to the study group, NMES will be applied to the upper trapezius muscle for 30 minutes 5 days a week for 4 weeks. Neuromuscular Electrical Stimulation (NMES) applications will be performed with a Compex 3 (Compex Medical SA, Ecublens, Switzerland) model, portable and programmable electrostimulator unit in rehabilitation mode and under the supervision of an expert physiotherapist experienced in the device and application. The NMES program will be applied with a 4-channel device with a functional stimulation capacity of 120 mA, pulse duration 400 μs and pulse frequency 150 Hz.
Study NCT06554106 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Group
Description: Patients will be taught neck normal joint movement exercises, upper trapezius stretching exercise and posture exercises.
Study NCT04826263 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home Exercise Program
Description: All patients will be instructed to follow a home exercise program for 3 weeks. Patients will be informed about the exercises by giving an exercise sheet describing the exercises and an exercise diary prepared to mark the days they exercise. The home exercise program will include previously recommended exercises such as Achilles tendon and plantar fascia stretching and toe curl exercises. Patients will be instructed to perform these exercises 10 repetitions each and 3 times per day for three weeks.
Study NCT04826263 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT)
Description: Patients in the LLLT group will receive gallium-aluminum-arsenide (Ga-Al-As) low-level laser treatment with Chattanooga Vectra Genisys Transport model (Chattanooga Group) with a wavelength of 850 nm and a power of 100 mW. The LLLT treatment will be applied 3 times a week, a total of 10 sessions. A maximum energy density of 5.6 j/cm2 will be reached by delivering a continuously increasing dose of energy to each tender spot for one minute. The LLLT will be performed with patients in the prone position and will be applied to 5 points on the plantar fascia by positioning the laser head perpendicular to the treatment area.
Study NCT04826263 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extracorporeal Shockwave Therapy (ESWT)
Description: Patients in the ESWT group will receive treatment with a radial ESWT system (EMS Swiss Dolor Clast), which transforms kinetic energy into a shock wave, which is then applied to the target tissue with pressure varying from 1 to 10 bar and penetrating up to 40 mm. The ESWT treatment will be administered to the patients once a week for three weeks, for a total dose of 2000 mJ/mm2 pulse per application. ESWT will be applied to the patients in prone position with their foot inverted. Ultrasound gel will be applied to the patient's heel The area of tenderness will be palpated and 1000 shock wave impulses were applied to this area, and 1000 pulses will be applied over the plantar fascia.
Study NCT04855240 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACP-044 Dose A
Description: Oral dose of ACP-044 Dose A
Study NCT04855240 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACP-044 Dose B
Description: Oral dose of ACP-044 Dose B
Study NCT04855240 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral dose of placebo
Study NCT05547087 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VN-0200
Description: VN-0200 (antigen: VAGA-9001a, adjuvant: MABH-9002b) administered as an intramuscular injection; 2 shots in 4 weeks.
Study NCT05547087 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: VN-0200
Description: VN-0200 (antigen: VAGA-9001a, adjuvant: MABH-9002b) administered as an intramuscular injection; 2 shots in 4 weeks.
Study NCT05779228 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mode Switching Training
Description: Wear of colored lenses for 1 hr, 5 times per day, for 5 days
Study NCT05429580 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Tranexamic acid
Description: given intravenous tranexamic acid
Study NCT05429580 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 5% Dextrose
Description: given placebo.
Study NCT05353114 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D feet scan (smart-fitting by Podiapp - Podartis s.r.l Unipersonale-Crocceta del Montello (TV), Italy).
Description: The 3D foot scan becomes a movile app that recommends a specific size and model of therapeutic footwear according to the measurements
Study NCT05976152 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dl-3-butylphthalide
Description: First stage： Routine stroke treatment: hypoglycemic, antihypertensive, antiplatelet, anticoagulant and other conventional cerebrovascular disease treatment drugs.~Placebo group: routine stroke treatment + oral Butylphthalide Placebo Soft Capsules, 2 capsules/time, tid, an empty stomach for 24 weeks.~Butylphthalide group: routine stroke treatment + oral Butylphthalide Soft Capsules, 2 capsules/time, tid, an empty stomach for 24 weeks.~Second stage： 14d washout period after first stage. Routine PSCI treatment: 5-10 mg Donepezil, qd. Placebo group: Routine PSCI treatment + oral Butylphthalide Placebo Soft Capsules, 2 capsules/time, tid, an empty stomach for 24 weeks.~Butylphthalide group:~Routine PSCI treatment + oral Butylphthalide Soft Capsules, 2 capsules/time, tid, an empty stomach for 24 weeks.